KONTICH, Belgium--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray ...

Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDONtm, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative ...

KONTICH, Belgium, February 27, 2025--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using ...

KONTICH, Belgium, February 27, 2025--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM ...

Bruker has been leading the expansion of atomic force microscope (AFM) capabilities since the very beginning, and our systems are the most cited AFMs in the world. Our comprehensive suite of AFMs ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...

Major players in the market Include Bruker, Nikon, Olympus, Zeiss, Oxford Instruments and Etaluma. Due to the presence of prominent players and increasing expenditure in R&D, North America has the ...

Such insights will support the development and commercialization of MCO-010, Nanoscope Therapeutics’ optogenetic gene therapy that is designed to restore vision and potentially slow ...

"We applaud Nanoscope Therapeutics for its commitment to improving therapies for vision-threatening diseases," said Sujay Jadhav, CEO of Verana Health. "Our collaboration underscores how data-driven ...